Sharma, B., Nannuru, K., Saxena, S., Varney, M., & Singh, R. (2019). CXCR2: A Novel Mediator of Mammary Tumor Bone Metastasis. International Journal of Molecular Sciences, 20(5). https://doi.org/10.3390/ijms20051237 (Original work published 2019)

Saxena, S., Purohit, A., Varney, M., Hayashi, Y., & Singh, R. (2018). Semaphorin-5A maintains epithelial phenotype of malignant pancreatic cancer cells. BMC Cancer, 18(1), 1283. https://doi.org/10.1186/s12885-018-5204-x (Original work published 2018)

Wu, S., Saxena, S., Varney, M., & Singh, R. CXCR1/2 Chemokine Network Regulates Melanoma Resistance to Chemotherapies Mediated by NF-κB. Current Molecular Medicine, 17(6), 436-449. https://doi.org/10.2174/1566524018666171219100158 (Original work published 2017)

Sharma, B., Varney, M., Saxena, S., Wu, L., & Singh, R. (2016). Induction of CXCR2 ligands, stem cell-like phenotype, and metastasis in chemotherapy-resistant breast cancer cells. Cancer Letters, 372(2), 192-200. https://doi.org/10.1016/j.canlet.2015.12.011 (Original work published 2016)

Saxena, S., Hayashi, Y., Wu, L., Awaji, M., Atri, P., Varney, M., … Singh, R. (2018). Pathological and functional significance of Semaphorin-5A in pancreatic cancer progression and metastasis. Oncotarget, 9(5), 5931-5943. https://doi.org/10.18632/oncotarget.23644 (Original work published 2018)